Dynamic variability in apoptotic threshold as a strategy for combating fractional killing
Abstract
Fractional killing, which is a significant impediment to successful chemotherapy, is observed even in a population of genetically identical cancer cells exposed to apoptosis-inducing agents. This phenomenon arises not from genetic mutation but from cell-to-cell variation in the activation timing and level of the proteins that regulate apoptosis. To understand the mechanism behind the phenomenon, we formulate complex fractional killing processes as a first-passage time (FPT) problem with a stochastically fluctuating boundary. Analytical calculations are performed for the FPT distribution in a toy model of stochastic p53 gene expression, where the cancer cell is killed only when the p53 expression level crosses an activity apoptotic threshold. Counterintuitively, we find that threshold fluctuations can effectively enhance cellular killing by significantly decreasing the mean time that the p53 protein reaches the threshold level for the first time. Moreover, faster fluctuations lead to the killing of more cells. These qualitative results imply that dynamic variability in threshold is an unneglectable stochastic source, and can be taken as a strategy for combating fractional killing of cancer cells.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Large-Scale Analysis of Cell Death Phenotypic Heterogeneity
Z. Inde, G. C. Forcina, … S. J. Dixon·bioRxiv·Feb 28, 2020
- Origins of fractional control in regulated cell death
LETÍCIA VITÓRIA DA SILVA SANTOS, ROBERT M. VOGEL, … Pablo Meyer·bioRxiv·Apr 10, 2018
- Interplay of p53 and XIAP protein dynamics orchestrates cell fate in response to chemotherapy
R. Abukwaik, E. Vera-Siguenza, … F. Spill·Journal of Theoretical BiologyPeer-reviewed·Sep 1, 2023
- A model for the intrinsic limit of cancer therapy: duality of treatment-induced cell death and treatment-induced stemness
E. Angelini, Y. Wang, … S. Huang·bioRxiv·Oct 5, 2021
- A stochastic population model for the impact of cancer cell dormancy on therapy success
- Matrix Stiffness Dictates Doxorubicin-Induced Apoptosis by Modulating Cell-Cycle State in HeLa Cells
Natalie Calahan, Scott R. Burlingham, … Soham Ghosh·bioRxiv·Nov 11, 2025